Bigger drug firms with 1 trillion won in sale to be foreseeable 10 years later

The domestic pharmaceutical industry cannot expect the emergence of any enterprises showing a 1 trillion-won revenue over the next 10 years due to the government’s senseless plan to cut drug prices by an average of 17 percent starting next year.

Korean companies are concerned by the potentially significant impact of the plan on the prices and profit margin of their products.

The overall r...